<div class="article">
	<h3>Who's News: Schering, SmithKline Name U.S. Executives</h3>
	<div class="article-info">
		<ul>
			<li>Author: A Wall Street Journal News Roundup</li>
			<li>Date: 09/05/90</li>
		</ul>
	</div>
	<p class="article-leader">Two big pharmaceutical companies named executives to head
their respective U.S. businesses.
   Schering-Plough Corp., Madison, N.J., said Rodolfo C.
Bryce was appointed president of Schering Laboratories, the
company's U.S. prescription-products unit. Mr. Bryce, 44
years old, previously was senior vice president, prescription
marketing and sales, at Schering Labs.</p>
	<div class="article-body"><p>Mr. Bryce succeeds Jean-Pierre Garnier, 43, who was named
president of the U.S. pharmaceuticals business of SmithKline
Beecham PLC, London, succeeding Frederick Kyle, who was named
president, commercial operations, of the Anglo-American drug
concern's world-wide operations earlier this year.</p>
<p></p></div>
</div>
